$GOSS Gossamer Bio, Inc. Insider Trading
Get free email notifications about insider trading in Gossamer Bio, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Gossamer Bio, Inc.. Insider overview, share value development, latest insider transactions and email notifications about new events in Gossamer Bio, Inc. for free.
CIK Number: 0001728117
IRS Number: 475461709
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Trading Symbol: GOSS
Company Address: 3013 SCIENCE PARK SAN DIEGO 92121
Phone number: (858) 922-0718
Former name: FSG Bio, Inc.
Gossamer Bio, Inc. Latest Insider Transactions
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 10 2021 | GOSS | Gossamer Bio, Inc. | Burow Kristina | Director | Option Exercise | A | 8.97 | 23,500 | 210,795 | 23,500 | |
May 05 2021 | GOSS | Gossamer Bio, Inc. | Carter Laura | Chief Scientific Of ... | Option Exercise | A | 8.70 | 31,750 | 276,225 | 31,750 | |
May 05 2021 | GOSS | Gossamer Bio, Inc. | Carter Laura | Chief Scientific Of ... | Grant | A | 0.00 | 10,820 | 0 | 72,683 | 61.9 K to 72.7 K (+17.49 %) |
Apr 20 2021 | GOSS | Gossamer Bio, Inc. | Peterson Caryn | EVP, Regulatory Aff ... | Option Exercise | A | 8.49 | 31,750 | 269,558 | 31,750 | |
Apr 20 2021 | GOSS | Gossamer Bio, Inc. | Peterson Caryn | EVP, Regulatory Aff ... | Grant | A | 0.00 | 10,820 | 0 | 74,828 | 64 K to 74.8 K (+16.90 %) |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | President & CEO | Option Exercise | A | 9.79 | 325,000 | 3,181,750 | 325,000 | |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Hasnain Faheem | President & CEO | Grant | A | 0.00 | 162,500 | 0 | 162,500 | 0 to 162.5 K |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Option Exercise | A | 9.79 | 90,000 | 881,100 | 90,000 | |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Option Exercise | A | 9.79 | 90,000 | 881,100 | 90,000 | |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Grant | A | 0.00 | 45,000 | 0 | 115,379 | 70.4 K to 115.4 K (+63.94 %) |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Giraudo Bryan | Chief Financial Off ... | Grant | A | 0.00 | 45,000 | 0 | 115,379 | 70.4 K to 115.4 K (+63.94 %) |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Christian Waage | EVP & General Couns ... | Option Exercise | A | 9.79 | 90,000 | 881,100 | 90,000 | |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Christian Waage | EVP & General Couns ... | Grant | A | 0.00 | 45,000 | 0 | 593,689 | 548.7 K to 593.7 K (+8.20 %) |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Christian Waage | EVP & General Couns ... | Option Exercise | A | 9.79 | 90,000 | 881,100 | 90,000 | |
Mar 01 2021 | GOSS | Gossamer Bio, Inc. | Christian Waage | EVP & General Couns ... | Grant | A | 0.00 | 45,000 | 0 | 593,689 | 548.7 K to 593.7 K (+8.20 %) |